Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination …
G Giammanco, A Moiraghi, C Zotti, S Pignato, SL Volti… - Vaccine, 1998 - Elsevier
The reactogenicity and immunogenicity of a tetravalent diphtheria-tetanus-acellular
pertussis-hepatitis B (DTPa-HB) vaccine (SmithKline Beecham) were studied in 565 infants …
pertussis-hepatitis B (DTPa-HB) vaccine (SmithKline Beecham) were studied in 565 infants …
Booster vaccination of adults with reduced-antigen-content diphtheria, tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination
PB McIntyre, MA Burgess, A Egan, L Schuerman… - Vaccine, 2009 - Elsevier
At 60 months post-vaccination, adults (mean age 45.6 years) randomised to receive
combined reduced-antigen-content diphtheria–tetanus and acellular pertussis vaccine …
combined reduced-antigen-content diphtheria–tetanus and acellular pertussis vaccine …
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-to 20-month-old children
ME Pichichero, MA Deloria, MB Rennels… - …, 1997 - publications.aap.org
Objective. To compare the safety and immunogenicity of 12 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2 …
S Sricharoenchai, C Sirivichayakul… - The Lancet Infectious …, 2018 - thelancet.com
Background Increasing evidence shows that protection induced by acellular pertussis
vaccines is short-lived, requiring repeated booster vaccination to control pertussis disease …
vaccines is short-lived, requiring repeated booster vaccination to control pertussis disease …
Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents
ME Pichichero, MM Blatter, WA Kennedy, J Hedrick… - …, 2006 - publications.aap.org
BACKGROUND. The incidence of pertussis is increasing, especially in adolescents,
attributed in part to waning of immunity after childhood immunization. Recently licensed in …
attributed in part to waning of immunity after childhood immunization. Recently licensed in …
Safety and immunogenicity of acellular pertussis vaccine, combined with diphtheria and tetanus as the Japanese commercial Takeda vaccine, compared with the …
B WATSON, A CAWEIN, BL MCKEE… - The Pediatric …, 1992 - journals.lww.com
A double blind, randomized, controlled trial compared the safety and immunogenicity of an
acellular pertussis vaccine formulated at Lederle using the Takeda acellular pertussis …
acellular pertussis vaccine formulated at Lederle using the Takeda acellular pertussis …
The effectiveness and safety of pertussis booster vaccination for adolescents and adults: A systematic review and meta-analysis
J Xu, S Liu, Q Liu, R Rong, W Tang, Q Wang, S Kuang… - Medicine, 2019 - journals.lww.com
Background: Due to the resurgence of pertussis, many countries have revised the pertussis
immunization schedules and recommended booster doses of pertussis component vaccine …
immunization schedules and recommended booster doses of pertussis component vaccine …
[PDF][PDF] Study of pertussis vaccines in infants: Comparison of response to acellular pertussis DTP vaccines containing 25 μg of FHA and either 25 or 8 μg of
H Vanura, M Just, F Ambrosch, RM Berger, H Bogaerts… - Vaccine, 1994 - academia.edu
Clinical and serological responses of infants to primary vaccination with diphtheriatetanus-
acellular pertussis (DTPa) vaccines containing 25# g of filamentous haemagglutinin (FHA) …
acellular pertussis (DTPa) vaccines containing 25# g of filamentous haemagglutinin (FHA) …
Feasibility study of a combined diphtheria-tetanus-acellular pertussis-hepatitis B (DTPa-HBV) vaccine, and comparison of clinical reactions and immune responses …
V Usonis, V Bakasenas, P Willems, R Clemens - Vaccine, 1997 - Elsevier
The feasibility of a combined diphtheria-tetanus-acellular pertussis-hepatitis B (DTPa-HBV)
vaccine was assessed and a comparison made of immunogenicity and reactogenicity to …
vaccine was assessed and a comparison made of immunogenicity and reactogenicity to …
Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine
S Lugauer, U Heininger, JD Cherry, K Stehr - European journal of …, 2002 - Springer
The objective of this open study was to monitor the long-term effectiveness of the Lederle-
Takeda diphtheria and tetanus toxoids and acellular pertussis antigen (s)(DTaP) vaccine …
Takeda diphtheria and tetanus toxoids and acellular pertussis antigen (s)(DTaP) vaccine …